Steven Messe, MD
Disclosures: Consultant-Boston Scientific Corporation-Embolic protection during transcatheter aortic valve replacement|Grants/Research Support Recipient-Biogen Idec-IV glyburide for malignant stroke edema|Grants/Research Support Recipient-Bayer Corporation-Rivaroxaban for embolic stroke of undetermined source|Grants/Research Support Recipient-Mallinckrodt, Inc.-Inhaled nitric oxide for stroke|Grants/Research Support Recipient-W. L. Gore and Associates, Inc.-PFO closure and stroke; Neurologic outcomes from proximal aortic disease
No Bio Available.